Cardea Bio

Cardea Bio is a United States-based company headquartered in San Diego with additional activity in Los Angeles. They specialize in the development and production of biocompatible semiconductors. As a small company with 12 employees, Cardea Bio focuses on bringing revolutionary technology to various sectors. Cardea Bio is the world's only mass producer of biocompatible semiconductors, known as the BPU™ (Biosignal Processing Unit). This groundbreaking semiconductor translates real-time streams of multiomics signals into digital information, enabling a new era of biological understanding. Their technology has applications across a wide range of industries, including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health. Cardea Bio's primary product, the BPU™, sets them apart from competitors. This unique semiconductor allows for the democratization of access to biosignals and the insights they provide, paving the way for the "Internet of Biology." The BPU™ platform offers unprecedented capabilities, allowing users to analyze biological data in real-time, with the portability and ease of use not previously available. For more information, visit Cardea Bio's website at cardeabio.com.